BlackRock Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

BlackRock Investment Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.58M	Sell	146,855 -465	-0.3%	-$22.8K	0.01%	1393
2016 Q3	$8.23M	Buy	147,320 +1,094	+0.7%	+$61K	0.01%	1133
2016 Q2	$7.31M	Buy	146,226 +33,992	+30%	+$1.67M	0.01%	1166
2016 Q1	$5.15M	Buy	112,234 +15,496	+16%	+$751K	0.01%	1358
2015 Q4	$5.96M	Buy	96,738 +620	+0.6%	+$43.6K	0.01%	1278
2015 Q3	$5.35M	Sell	96,118 -1,515	-2%	-$95.3K	0.01%	1334
2015 Q2	$5.95M	Buy	97,633 +71,290	+271%	+$4.07M	0.01%	1366
2015 Q1	$1.52M	Sell	26,343 -3,231	-11%	-$217K	﹤0.01%	2220
2014 Q4	$1.71M	Buy	29,574 +6,209	+27%	+$261K	﹤0.01%	2147
2014 Q3	$666K	Buy	+23,365	New	+$578K	﹤0.01%	2803

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BlackRock Investment Management's KITE Position: Q4 2016 in Review

BlackRock Investment Management reduced its Kite Pharma, Inc. (KITE) stake by 0.32% in Q4 2016, selling an estimated $22.8K and leaving 146,855 shares worth $6.58M. The position accounts for 0.01% of the portfolio, ranked #1393.

BlackRock Investment Management first reported a position in KITE in Q3 2014 and has held it in 10 quarters since. The position peaked at $8.23M in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

BlackRock Investment Management held 146,855 shares of Kite Pharma, Inc. worth $6.58M as of Q4 2016.
BlackRock Investment Management sold 465 Kite Pharma, Inc. shares in Q4 2016, an estimated $22.8K.
Kite Pharma, Inc. made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1393 holding.
BlackRock Investment Management first reported a position in Kite Pharma, Inc. in Q3 2014 and has held it in 10 quarters since.
BlackRock Investment Management's Kite Pharma, Inc. position peaked at $8.23M in Q3 2016.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.